853 related articles for article (PubMed ID: 26835592)
1. Fused Mycobacterium tuberculosis multi-stage immunogens with an Fc-delivery system as a promising approach for the development of a tuberculosis vaccine.
Mosavat A; Soleimanpour S; Farsiani H; Sadeghian H; Ghazvini K; Sankian M; Jamehdar SA; Rezaee SA
Infect Genet Evol; 2016 Apr; 39():163-172. PubMed ID: 26835592
[TBL] [Abstract][Full Text] [Related]
2. Fc-based delivery system enhances immunogenicity of a tuberculosis subunit vaccine candidate consisting of the ESAT-6:CFP-10 complex.
Farsiani H; Mosavat A; Soleimanpour S; Sadeghian H; Akbari Eydgahi MR; Ghazvini K; Sankian M; Aryan E; Jamehdar SA; Rezaee SA
Mol Biosyst; 2016 Jun; 12(7):2189-201. PubMed ID: 27138226
[TBL] [Abstract][Full Text] [Related]
3. APC targeting enhances immunogenicity of a novel multistage Fc-fusion tuberculosis vaccine in mice.
Soleimanpour S; Farsiani H; Mosavat A; Ghazvini K; Eydgahi MR; Sankian M; Sadeghian H; Meshkat Z; Rezaee SA
Appl Microbiol Biotechnol; 2015 Dec; 99(24):10467-80. PubMed ID: 26373723
[TBL] [Abstract][Full Text] [Related]
4. Construction and immunogenicity of a new Fc-based subunit vaccine candidate against Mycobacterium tuberculosis.
Kebriaei A; Derakhshan M; Meshkat Z; Eidgahi MR; Rezaee SA; Farsiani H; Mosavat A; Soleimanpour S; Ghazvini K
Mol Biol Rep; 2016 Sep; 43(9):911-22. PubMed ID: 27251218
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity and protective efficacy of a fusion protein vaccine consisting of antigen Ag85B and HspX against Mycobacterium tuberculosis infection in mice.
Li Q; Yu H; Zhang Y; Wang B; Jiang W; Da Z; Xian Q; Wang Y; Liu X; Zhu B
Scand J Immunol; 2011 Jun; 73(6):568-76. PubMed ID: 21323695
[TBL] [Abstract][Full Text] [Related]
6. CFP10: mFcγ2 as a novel tuberculosis vaccine candidate increases immune response in mouse.
Baghani AA; Soleimanpour S; Farsiani H; Mosavat A; Yousefi M; Meshkat Z; Rezaee SA; Jamehdar SA; Eydgahi MR; Sadeghian H; Ghazvini K
Iran J Basic Med Sci; 2017 Feb; 20(2):122-130. PubMed ID: 28293387
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine expressing a fusion protein of Ag85B-Esat6-HspX in mice.
Yuan W; Dong N; Zhang L; Liu J; Lin S; Xiang Z; Qiao H; Tong W; Qin C
Vaccine; 2012 Mar; 30(14):2490-7. PubMed ID: 21704108
[TBL] [Abstract][Full Text] [Related]
8. Construction and evaluation of a multistage Mycobacterium tuberculosis subunit vaccine candidate Mtb10.4-HspX.
Niu H; Hu L; Li Q; Da Z; Wang B; Tang K; Xin Q; Yu H; Zhang Y; Wang Y; Ma X; Zhu B
Vaccine; 2011 Nov; 29(51):9451-8. PubMed ID: 22024175
[TBL] [Abstract][Full Text] [Related]
9. Enhanced and durable protective immune responses induced by a cocktail of recombinant BCG strains expressing antigens of multistage of Mycobacterium tuberculosis.
Liang J; Teng X; Yuan X; Zhang Y; Shi C; Yue T; Zhou L; Li J; Fan X
Mol Immunol; 2015 Aug; 66(2):392-401. PubMed ID: 25974877
[TBL] [Abstract][Full Text] [Related]
10. Protection against Mycobacterium tuberculosis infection offered by a new multistage subunit vaccine correlates with increased number of IFN-γ+ IL-2+ CD4+ and IFN-γ+ CD8+ T cells.
Wang X; Zhang J; Liang J; Zhang Y; Teng X; Yuan X; Fan X
PLoS One; 2015; 10(3):e0122560. PubMed ID: 25822536
[TBL] [Abstract][Full Text] [Related]
11. Production and Evaluation of Ag85B:HspX:hFcγ1 Immunogenicity as an Fc Fusion Recombinant Multi-Stage Vaccine Candidate Against Mycobacterium tuberculosis.
Karbalaei M; Mosavat A; Soleimanpour S; Farsiani H; Ghazvini K; Amini AA; Sankian M; Rezaee SA
Curr Microbiol; 2024 Apr; 81(5):127. PubMed ID: 38575759
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and protective efficacy conferred by a novel recombinant Mycobacterium bovis bacillus Calmette-Guérin strain expressing interleukin-12p70 of human cytokine and Ag85A of Mycobacterium tuberculosis fusion protein.
Deng YH; He HY; Zhang FJ
Scand J Immunol; 2013 Dec; 78(6):497-506. PubMed ID: 24283772
[TBL] [Abstract][Full Text] [Related]
13. Cloning, expression, and immunogenicity of novel fusion protein of Mycobacterium tuberculosis based on ESAT-6 and truncated C-terminal fragment of HSP70.
Tebianian M; Hoseini AZ; Ebrahimi SM; Memarnejadian A; Mokarram AR; Mahdavi M; Sohrabi N; Taghizadeh M
Biologicals; 2011 May; 39(3):143-8. PubMed ID: 21388826
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic efficacy of a tuberculosis DNA vaccine encoding heat shock protein 65 of Mycobacterium tuberculosis and the human interleukin 2 fusion gene.
Changhong S; Hai Z; Limei W; Jiaze A; Li X; Tingfen Z; Zhikai X; Yong Z
Tuberculosis (Edinb); 2009 Jan; 89(1):54-61. PubMed ID: 19056317
[TBL] [Abstract][Full Text] [Related]
15. Performance of Homologous and Heterologous Prime-Boost Immunization Regimens of Recombinant Adenovirus and Modified Vaccinia Virus Ankara Expressing an Ag85B-TB10.4 Fusion Protein against
Kou Y; Wan M; Shi W; Liu J; Zhao Z; Xu Y; Wei W; Sun B; Gao F; Cai L; Jiang C
J Microbiol Biotechnol; 2018 Jun; 28(6):1022-1029. PubMed ID: 29847865
[TBL] [Abstract][Full Text] [Related]
16. A Promising Listeria-Vectored Vaccine Induces Th1-Type Immune Responses and Confers Protection Against Tuberculosis.
Yin Y; Lian K; Zhao D; Tao C; Chen X; Tan W; Wang X; Xu Z; Hu M; Rao Y; Zhou X; Pan Z; Zhang X; Jiao X
Front Cell Infect Microbiol; 2017; 7():407. PubMed ID: 29034213
[TBL] [Abstract][Full Text] [Related]
17. IL-28B down-regulates regulatory T cells but does not improve the protective immunity following tuberculosis subunit vaccine immunization.
Luo Y; Ma X; Liu X; Lu X; Niu H; Yu H; Bai C; Peng J; Xian Q; Wang Y; Zhu B
Int Immunol; 2016 Feb; 28(2):77-85. PubMed ID: 26521300
[TBL] [Abstract][Full Text] [Related]
18. A novel recombinant BCG-expressing pro-apoptotic protein BAX enhances Th1 protective immune responses in mice.
Li G; Liu G; Song N; Kong C; Huang Q; Su H; Bi A; Luo L; Zhu L; Xu Y; Wang H
Mol Immunol; 2015 Aug; 66(2):346-56. PubMed ID: 25942359
[TBL] [Abstract][Full Text] [Related]
19. Immunological properties of recombinant Mycobacterium bovis bacillus Calmette-Guérin strain expressing fusion protein IL-2-ESAT-6.
Fan XL; Yu TH; Gao Q; Yao W
Acta Biochim Biophys Sin (Shanghai); 2006 Oct; 38(10):683-90. PubMed ID: 17033714
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of immune response against Mycobacterium tuberculosis HspX antigen by incorporation of combined molecular adjuvant (CASAC).
Lew MH; Norazmi MN; Tye GJ
Mol Immunol; 2020 Jan; 117():54-64. PubMed ID: 31739193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
